MSB 1.78% $1.11 mesoblast limited

Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-573

  1. 2,261 Posts.
    lightbulb Created with Sketch. 367
    heres the article

    https://www.eurekalert.org/pub_releases/2020-11/thi-thi111820.php

    No, I think more like its a we are starting another trial already so we can get an EUA or AP up?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.